AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Natwest Group PLC

Director's Dealing Jul 2, 2025

4644_dirs_2025-07-02_bc4b0e8c-2377-4370-80d8-bdb0272735e5.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4568P

NatWest Group plc

02 July 2025

2 July 2025

NatWest Group plc

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) in accordance with Article 19 of the Market Abuse Regulation

NatWest Group plc (the Company) announces that the PDMRs set out below purchased ordinary shares of £1.0769* each in the Company (Shares) (ISIN: GB00BM8PJY71) on 01 July 2025 at the price indicated, in accordance with the Company's Chairman and Non-executive Director shareholding policy:

Name of PDMR Position of PDMR No. of Shares purchased Price of Shares purchased
Rick Haythornthwaite Chairman 2,378 £5.0100
Roisin Donnelly Independent non-executive director 619 £5.0100
Patrick Flynn Independent non-executive director 255 £5.0100
Geeta Gopalan Independent non-executive director 620 £5.0100
Yasmin Jetha Independent non-executive director 239 £5.0100
Stuart Lewis Independent non-executive director 636 £5.0100
Gillian Whitehead Independent non-executive director 659 £5.0100
Lena Wilson Senior Independent Director 236 £5.0100

The transactions took place on the London Stock Exchange (XLON).

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share.  

Legal Entity Identifier: 2138005O9XJIJN4JPN90

For further information contact:-

NatWest Group Investor Relations

Claire Kane

Director of Investor Relations

+44 20 7672 1758

NatWest Group Media Relations  

+44(0)131 523 4205

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSSLFEEEISEIW

Talk to a Data Expert

Have a question? We'll get back to you promptly.